Nutraceutical approaches to metabolic syndrome

被引:24
作者
Sirtori, Cesare R. [1 ]
Pavanello, Chiara [2 ]
Calabresi, Laura [2 ]
Ruscica, Massimiliano [3 ]
机构
[1] ASST Grande Osped Metropolitano Niguarda, Ctr Dislipidemie, Milan, Italy
[2] Univ Milan, Ctr E Grossi Paoletti, Dipartimento Sci Farmacol & Biomol, Milan, Italy
[3] Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy
关键词
Metabolic syndrome; nutraceuticals; probiotics; berberine and vitamin D; RED YEAST RICE; TYPE-2; DIABETES-MELLITUS; VITAMIN-D DEFICIENCY; C-REACTIVE PROTEIN; IMPROVES LIPID PATTERN; BODY-MASS INDEX; KEXIN TYPE 9; BLOOD-PRESSURE; GUT MICROBIOTA; INSULIN-RESISTANCE;
D O I
10.1080/07853890.2017.1366042
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Metabolic Syndrome (MetS), affecting at least 30% of adults in the Western World, is characterized by three out of five variables, from high triglycerides, to elevated waist circumference and blood pressure. MetS is not characterized by elevated cholesterolemia, but is rather the consequence of a complex interaction of factors generally leading to increased insulin resistance. Drug treatments are of difficult handling, whereas well-characterized nutraceuticals may offer an effective alternative. Among these, functional foods, e.g. plant proteins, have been shown to improve insulin resistance and reduce triglyceride secretion. Pro-and pre-biotics, that are able to modify intestinal microbiome, reduce absorption of specific nutrients and improve the metabolic handling of energy-rich foods. Finally, specific nutraceuticals have proven to be of benefit, in particular, red-yeast rice, berberine, curcumin as well as vitamin D. All these can improve lipid handling by the liver as well as ameliorate insulin resistance. While lifestyle approaches, such as with the Mediterranean diet, may prove to be too complex for the single patient, better knowledge of selected nutraceuticals and more appropriate formulations leading to improved bio-availability will certainly widen the use of these agents, already in large use for the management of these very frequent patient groups.
引用
收藏
页码:678 / 697
页数:20
相关论文
共 204 条
[1]   Relationship between obesity, insulin resistance, and coronary heart disease risk [J].
Abbasi, F ;
Brown, BW ;
Lamendola, C ;
McLaughlin, T ;
Reaven, GM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (05) :937-943
[2]   Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study [J].
Affuso, F. ;
Ruvolo, A. ;
Micillo, F. ;
Sacca, L. ;
Fazio, S. .
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2010, 20 (09) :656-661
[3]   Effects of probiotic supplementation in patients with type 2 diabetes: systematic review and meta-analysis [J].
Akbari, Vajihe ;
Hendijani, Fatemeh .
NUTRITION REVIEWS, 2016, 74 (12) :774-785
[4]   Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity [J].
Alberti, K. G. M. M. ;
Eckel, Robert H. ;
Grundy, Scott M. ;
Zimmet, Paul Z. ;
Cleeman, James I. ;
Donato, Karen A. ;
Fruchart, Jean-Charles ;
James, W. Philip T. ;
Loria, Catherine M. ;
Smith, Sidney C., Jr. .
CIRCULATION, 2009, 120 (16) :1640-1645
[5]   The metabolic syndrome - a new worldwide definition [J].
Alberti, KGMM ;
Zimmet, P ;
Shaw, J .
LANCET, 2005, 366 (9491) :1059-1062
[6]   The Role of Vitamin D in the Prevention of Type 2 Diabetes: To D or Not to D? [J].
Angellotti, Edith ;
Pittas, Anastassios G. .
ENDOCRINOLOGY, 2017, 158 (07) :2013-2021
[7]  
[Anonymous], LIPOPROTEINS DIABETE
[8]  
[Anonymous], 1000
[9]  
[Anonymous], PLOS ONE
[10]  
[Anonymous], 2018, EUR J NUTR, DOI DOI 10.1007/s00394-016-1333-7